CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 156 filers reported holding CASTLE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,858 | +34.2% | 8,103 | +9.0% | 0.01% | +25.0% |
| Q2 2023 | $101,952 | -35.8% | 7,431 | +6.3% | 0.00% | -33.3% |
| Q1 2023 | $158,789 | -3.2% | 6,989 | +0.3% | 0.01% | 0.0% |
| Q4 2022 | $164,096 | -12.7% | 6,971 | -3.6% | 0.01% | -25.0% |
| Q3 2022 | $188,000 | +1609.1% | 7,228 | +1223.8% | 0.01% | – |
| Q2 2022 | $11,000 | -59.3% | 546 | -8.7% | 0.00% | -100.0% |
| Q1 2022 | $27,000 | +42.1% | 598 | +30.0% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | -48.6% | 460 | -18.0% | 0.00% | 0.0% |
| Q3 2021 | $37,000 | +32.1% | 561 | +46.9% | 0.00% | -50.0% |
| Q2 2021 | $28,000 | +55.6% | 382 | +41.0% | 0.00% | +100.0% |
| Q1 2021 | $18,000 | -18.2% | 271 | -18.4% | 0.00% | 0.0% |
| Q4 2020 | $22,000 | +144.4% | 332 | +81.4% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | – | 183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |